Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
Plus de filtres











Gamme d'année
1.
Hippocampus ; 29(12): 1150-1164, 2019 12.
Article de Anglais | MEDLINE | ID: mdl-31381216

RÉSUMÉ

Accumulation of amyloid-beta (Aß) in temporal lobe structures, including the hippocampus, is related to a variety of Alzheimer's disease symptoms and seems to be involved in the induction of neural network hyperexcitability and even seizures. Still, a direct evaluation of the pro-epileptogenic effects of Aß in vivo, and of the underlying mechanisms, is missing. Thus, we tested whether the intracisternal injection of Aß modulates 4-aminopyridine (4AP)-induced epileptiform activity, hippocampal network function, and its synaptic coupling. When tested 3 weeks after its administration, Aß (but not its vehicle) reduces the latency for 4AP-induced seizures, increases the number of generalized seizures, exacerbates the time to fully recover from seizures, and favors seizure-induced death. These pro-epileptogenic effects of Aß correlate with a reduction in the power of the spontaneous hippocampal network activity, involving all frequency bands in vivo and only the theta band (4-10 Hz) in vitro. The pro-epileptogenic effects of Aß also correlate with a reduction of the Schaffer-collateral CA1 synaptic coupling in vitro, which is exacerbated by the sequential bath application of 4-AP and Aß. In summary, Aß produces long-lasting pro-epileptic effects that can be due to alterations in the hippocampal circuit, impacting its coordinated network activity and its synaptic efficiency. It is likely that normalizing synaptic coupling and/or coordinated neural network activity (i.e., theta activity) may contribute not only to improve cognitive function in Alzheimer's disease but also to avoid hyperexcitation in conditions of amyloidosis.


Sujet(s)
4-Amino-pyridine/toxicité , Peptides bêta-amyloïdes/toxicité , Hippocampe/physiopathologie , Fragments peptidiques/toxicité , Crises épileptiques/induit chimiquement , Crises épileptiques/physiopathologie , Synapses/physiologie , Animaux , Citerne cérébellomédullaire postérieure/effets des médicaments et des substances chimiques , Citerne cérébellomédullaire postérieure/physiopathologie , Potentiels post-synaptiques excitateurs/effets des médicaments et des substances chimiques , Potentiels post-synaptiques excitateurs/physiologie , Hippocampe/effets des médicaments et des substances chimiques , Mâle , Réseau nerveux/effets des médicaments et des substances chimiques , Réseau nerveux/physiopathologie , Techniques de culture d'organes , Inhibiteurs des canaux potassiques/toxicité , Rats , Rat Wistar , Synapses/effets des médicaments et des substances chimiques
2.
Childs Nerv Syst ; 34(8): 1593-1597, 2018 08.
Article de Anglais | MEDLINE | ID: mdl-29557511

RÉSUMÉ

INTRODUCTION: Focal hydrocephalus including trapped temporal horn (TTH), isolated lateral and fourth ventricles, is caused by obstruction and/or adhesion related to various etiologies. With the advent of the neuroendoscope, endoscopic procedures have become an alternative in selected cases. CASE REPORT: A 2-year-old male from a rural town in México was referred to our institution because of multiple supra- and infra-tentorial abscesses and hydrocephalus. The patient had progressive deterioration and developed bilateral trapped temporal horn related to multi-septated hydrocephalus, so we performed an endoscopic ventricular-cistern-ventriculostomy through a single right temporal burr hole. POSTOPERATIVE COURSE: Bilateral TTH and multi-septated hydrocephalus were effectively treated with a single external ventricular drainage (EVD) catheter, from the right temporal horn to the left temporal horn through the interpeduncular cistern; after clamping the EVD for 3 days with no evidence of hydrocephalus, the EVD was removed. The size of the ventricles remained stable afterwards, and no clinical or radiological evidence of hydrocephalus was observed after 3 months of follow-up. DISCUSSION: Endoscopic ventriculocisternostomy is effective in selected cases of TTH. We know that dilatation of the temporal horn widens the window between the anterior choroidal artery and optic tract superiorly, and the posterior communicating and CN III inferiorly, making the described procedure feasible, even in the approach to the contralateral side. Even though this is a rare condition, we believe it is a safe and effective option to eliminate multiple shunts and/or to reduce the number of catheters needed to treat bilateral THH related to multi-septated hydrocephalus.


Sujet(s)
Ventricules cérébraux/imagerie diagnostique , Citerne cérébellomédullaire postérieure/imagerie diagnostique , Mycoses/imagerie diagnostique , Neuroendoscopie/méthodes , Lobe temporal/imagerie diagnostique , Ventriculostomie/méthodes , Antifongiques/usage thérapeutique , Ventricules cérébraux/chirurgie , Enfant d'âge préscolaire , Citerne cérébellomédullaire postérieure/effets des médicaments et des substances chimiques , Citerne cérébellomédullaire postérieure/chirurgie , Humains , Hydrocéphalie/imagerie diagnostique , Hydrocéphalie/traitement médicamenteux , Mâle , Mycoses/traitement médicamenteux , Mycoses/chirurgie , Lobe temporal/chirurgie , Résultat thérapeutique
3.
Braz J Biol ; 73(3): 623-7, 2013 Aug.
Article de Anglais | MEDLINE | ID: mdl-24212704

RÉSUMÉ

Uroguanylin (UGN) is an endogenous peptide that acts on membrane-bound guanylate cyclase receptors of intestinal and renal cells increasing cGMP production and regulating electrolyte and water epithelial transport. Recent research works demonstrate the expression of this peptide and its receptor in the central nervous system. The current work was undertaken in order to evaluate modifications of electroencephalographic spectra (EEG) in anesthetized Wistar rats, submitted to intracisternal infusion of uroguanylin (0.0125 nmoles/min or 0.04 nmoles/min). The current observations demonstrate that 0.0125 nmoles/min and 0.04 nmoles/min intracisternal infusion of UGN significantly enhances amplitude and frequency of sharp waves and evoked spikes (p = 0.03). No statistical significance was observed on absolute alpha and theta spectra amplitude. The present data suggest that UGN acts on bioelectrogenesis of cortical cells by inducing hypersynchronic firing of neurons. This effect is blocked by nedocromil, suggesting that UGN acts by increasing the activity of chloride channels.


Sujet(s)
Électroencéphalographie/effets des médicaments et des substances chimiques , Peptides natriurétiques/pharmacologie , Animaux , Citerne cérébellomédullaire postérieure/effets des médicaments et des substances chimiques , Perfusions intraventriculaires , Mâle , Rats , Rat Wistar
4.
Braz. j. biol ; Braz. j. biol;73(3): 623-627, ago. 2013. tab, graf
Article de Anglais | LILACS | ID: lil-689848

RÉSUMÉ

Uroguanylin (UGN) is an endogenous peptide that acts on membrane-bound guanylate cyclase receptors of intestinal and renal cells increasing cGMP production and regulating electrolyte and water epithelial transport. Recent research works demonstrate the expression of this peptide and its receptor in the central nervous system. The current work was undertaken in order to evaluate modifications of electroencephalographic spectra (EEG) in anesthetized Wistar rats, submitted to intracisternal infusion of uroguanylin (0.0125 nmoles/min or 0.04 nmoles/min). The current observations demonstrate that 0.0125 nmoles/min and 0.04 nmoles/min intracisternal infusion of UGN significantly enhances amplitude and frequency of sharp waves and evoked spikes (p = 0.03). No statistical significance was observed on absolute alpha and theta spectra amplitude. The present data suggest that UGN acts on bioelectrogenesis of cortical cells by inducing hypersynchronic firing of neurons. This effect is blocked by nedocromil, suggesting that UGN acts by increasing the activity of chloride channels.


A uroguanilina (UGN) é um peptídeo endógeno que age em receptores do tipo guanilato ciclase de membrana de células intestinais e renais aumentando a produção de GMPc e regulando o transporte epitelial de eletrólitos e água. Pesquisas recentes demonstraram a expressão deste peptídeo e de seus receptores no sistema nervosa central. O presente trabalho foi realizado com objetivo de avaliar possíveis mudanças no espectro do eletroencefalograma (EEG) de ratos Wistar anestesiados, submetidos à infusão intracisternal de uroguanilina (0.0125 nmoles/min or 0.04 nmoles/min). Os resultados apresentados no corrente trabalho demonstram que a infusão intracisternal de ambas as doses de UGN aumenta significativamente a amplitude e frequência das espículas (p = 0.03). Não foram encontradas diferenças estatísticas na amplitude absoluta dos espectros alfa ou teta. Os dados apresentados neste trabalho mostram que a UGN age na bioeletrogênese de células corticais induzindo disparo hipersincrônico de neurônios. Este efeito é bloqueado por nedocromil, sugerindo que UGN atua pelo aumento de atividade de canais de cloreto.


Sujet(s)
Animaux , Mâle , Rats , Électroencéphalographie/effets des médicaments et des substances chimiques , Peptides natriurétiques/pharmacologie , Citerne cérébellomédullaire postérieure/effets des médicaments et des substances chimiques , Perfusions intraventriculaires , Rat Wistar
5.
Neurotoxicology ; 32(3): 350-4, 2011 Jun.
Article de Anglais | MEDLINE | ID: mdl-21377490

RÉSUMÉ

The present studies were conducted to changes arising from mercury poisoning in the central nervous system (CNS), with a focus on determining the receptors and neurotransmitters involved. Currently, little is known regarding the neurological basis of the cardiopulmonary effects of mercury poisoning. We evaluated changes in systolic arterial pressure (SAP), diastolic arterial pressure (DAP), respiratory rate (RR) and heart rate (HR) following a 5 µl intracisternal (i.c) injection of mercuric chloride (HgCl(2)) and the participation of the autonomic nervous system in these responses. 58 animals were utilized and distributed randomly into 10 groups and administered a 5 µL intracisternal injection of 0.68 µg/kg HgCl(2) (n=7), 1.2 µg/kg HgCl(2) (n=7), 2.4 µg/kg HgCl(2) (n=7), 60 µg/kg HgCl(2) (n=7), 120 µg/kg HgCl(2) (n=3), saline (control) (n=7), 60 µg/kg HgCl(2) plus prazosin (n=6), saline plus prazosin (n=6), 60 µg/kg HgCl(2) plus metilatropina (n=4) or saline plus metilatropina (n=4)HgCl(2). Anesthesia was induced with halothane and maintained as needed with urethane (1.2 g/kg) administered intravenously (i.v.) through a cannula placed in the left femoral vein. The left femoral artery was also cannulated to record systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and heart rate (HR). A tracheotomy was performed to record respiratory rate. Animals were placed in a stereotaxic frame, and the cisterna magna was exposed. After a stabilization period, solutions (saline or HgCl(2)) were injected i.c., and cardiopulmonary responses were recorded for 50 min. Involvement of the autonomic nervous system was assessed through the i.v. injection of hexamethonium (20 mg/kg), prazosin (1 mg/kg) and methylatropine (1 mg/kg) 10 min before the i.c. injection of HgCl(2) or saline. Treatment with 0.68, 1.2, 2.4 µg/kg HgCl(2) or saline did not modify basal cardiorespiratory parameters, whereas the 120 µg/kg dose induced acute toxicity, provoking respiratory arrest and death. The administration of 60 µg/kg HgCl(2), however, induced significant increases (p<0.05) in SAP at the 30°, 40° and 50° min, timepoints and DAP at the 5°, 10°, 20°, 30°, 40° and 50° timepoints. RR was significantly decreased at the 5°, 10°, 20°, 40° and 50° min timepoints; however, there was no change in HR. Hexamethonium administration, which causes non-specific inhibition of the autonomic nervous system, abolished the observed cardiorespiratory effects. Similarly, prazosin, a α(1)-adrenoceptor blocker that specifically inhibits sympathetic nervous system function, abolished HgCl(2) induced increases in SAP and DAP without affecting HR and RR. Methylatropine (1 mg/Kg), a parasympathetic nervous system inhibitor, exacerbated the effects of HgCl(2) and caused slow-onset respiratory depression, culminating in respiratory arrest and death. Our results demonstrate that increases in SAP and DAP induced by the i.c. injection of mercuric chloride are mediated by activation of the sympathetic nervous system.


Sujet(s)
Système nerveux autonome/effets des médicaments et des substances chimiques , Pression sanguine/effets des médicaments et des substances chimiques , Citerne cérébellomédullaire postérieure/effets des médicaments et des substances chimiques , Polluants environnementaux/toxicité , Rythme cardiaque/effets des médicaments et des substances chimiques , Chlorure de mercure II/toxicité , Troubles neurologiques de l'intoxication par le mercure/étiologie , Fréquence respiratoire/effets des médicaments et des substances chimiques , Antagonistes des récepteurs alpha-1 adrénergiques/administration et posologie , Analyse de variance , Animaux , Système nerveux autonome/physiopathologie , Citerne cérébellomédullaire postérieure/physiopathologie , Relation dose-effet des médicaments , Polluants environnementaux/administration et posologie , Mâle , Chlorure de mercure II/administration et posologie , Troubles neurologiques de l'intoxication par le mercure/physiopathologie , Troubles neurologiques de l'intoxication par le mercure/prévention et contrôle , Microinjections , Antagonistes nicotiniques/administration et posologie , Parasympatholytiques/administration et posologie , Rats , Rat Wistar , Facteurs temps
6.
Clin Exp Pharmacol Physiol ; 34(11): 1126-30, 2007 Nov.
Article de Anglais | MEDLINE | ID: mdl-17880365

RÉSUMÉ

1. S100B is a calcium-binding protein that acts as a neurotrophic cytokine and is expressed in the central nervous system, predominantly by astrocytes. At nanomolar concentrations, S100B stimulates neurite outgrowth and glial glutamate uptake, as well as protecting neurons against glutamate excitoxicity. 2. Peripheral S100B concentrations, particularly in the serum and cerebrospinal fluid (CSF), have been used as a parameter of glial activation or death in several physiological and pathological conditions. 3. In the present study, we investigated the effect of anaesthetics (thiopental, ketamine and halothane) on CSF concentrations of S100B, as well as a possible sex dependence, because several studies have suggested astrocytes as putative targets for oestrogen. 4. Higher levels of CSF S100B were found when rats were anaesthetized with thiopental; these levels, independently of anaesthetic, were sex dependent. Conversely, no effect of anaesthetic or sex was observed on serum concentrations of S100B. 5. The increase in CSF concentrations of S100B induced by thiopental was confirmed in non-anaesthetized neonatal rats and cortical astrocyte cultures. 6. Assuming CSF S100B as a marker of development, glial activation or even brain damage, investigations regarding the sex dependence of its concentration may be useful in gaining an understanding of sex variations in the behaviour and the pathological course of, as well as susceptibility to, many brain disorders. The findings of the present study reinforce the sex effect on synaptic plasticity and suggest a sex dependence of neural communication mediated by extracellular S100B without restricting the influence of astrocytes on the developmental phase.


Sujet(s)
Anesthésiques/pharmacologie , Astrocytes/effets des médicaments et des substances chimiques , Cortex cérébral/effets des médicaments et des substances chimiques , Citerne cérébellomédullaire postérieure/effets des médicaments et des substances chimiques , Halothane/pharmacologie , Kétamine/pharmacologie , Facteurs de croissance nerveuse/liquide cérébrospinal , Protéines S100/liquide cérébrospinal , Thiopental/pharmacologie , Animaux , Animaux nouveau-nés , Astrocytes/métabolisme , Cellules cultivées , Cortex cérébral/cytologie , Cortex cérébral/métabolisme , Citerne cérébellomédullaire postérieure/métabolisme , Femelle , Mâle , Rats , Rat Wistar , Sous-unité bêta de la protéine liant le calcium S100 , Facteurs sexuels
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE